![](https://investorshub.advfn.com/uicon/374489.png?cb=1595535472)
Sunday, October 21, 2018 1:01:21 PM
Press Release | 10/20/2018
On October 19, 2018, Amarantus Biocience Holdings, Inc. (OTCPK: AMBS, AMBS, or the Company) entered into a term sheet with institutional investors (the Investors) to raise $700,000 in senior secured convertible debt (the Notes) for the primary purpose of supporting a joint venture (the JV) proposal submitted by the Company to MER Telemanagement Solutions (NASDAQ:MTSL, MTSL). The Notes would be secured by 1,098,000 shares of MTSL that would be owned by the Company in the event the JV offer presented by the Company to MTSL is accepted.
https://www.otcmarkets.com/stock/AMBS/news
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM